Skip to content

Public FDA record

Z-2992-2018: VidiStar(TM) PACS & DICOM Viewer Software system

Recall record Z-2992-2018 for Hitachi Healthcare Americas Corp Informatics Division. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2992-2018
Company in FDA record
Hitachi Healthcare Americas Corp Informatics Division
FDA record creation date
Sep 6, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The secure filesystem client software used in the interface between the Vidistar PACS and an EHR system may cause intermixed images from multiple patients showing in a single study.

Source facts

Action
The firm initiated the recall by email on 08/28/2018. The firm will be removing the 3rd party software from the interface and replacing it with new software and notify the affected customers when the action is completed.
Initiated
2018-08-28
Root cause
Software in the Use Environment
Terminated
2021-02-11
Distribution
SC, CO, IL, AZ, MT, OH, IN, TX, GA, MA
Recall number
Z-2992-2018
Recall status
Terminated
CDRH record ID
166868
FDA record created
2018-09-06
Recall event number
80896

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗